NASDAQ:SNGX
Soligenix, Inc Stock News
$0.405
+0 (+0%)
At Close: May 03, 2024
Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket
11:40am, Tuesday, 27'th Dec 2022 Benzinga
Gainers
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 106.9% to $0.5482 in pre-market trading on heavy volume.
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) rose 61.6% to $5.01 in pre
7 Stocks to Add to Your 10x Watchlist
12:09pm, Friday, 16'th Dec 2022
There are few things that get growth investors excited like the opportunity to invest in 10x stocks. By definition, these 10x stocks (also referred to as 10 baggers) can add huge gains to your portfol
Investor Summit Group Announces Soligenix, Inc. To Present at Q4 Conference
09:30am, Friday, 11'th Nov 2022
Princeton, New Jersey--(Newsfile Corp. - November 11, 2022) - Investor Summit Group, today announced that Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company) will attend the Q4 Investor Summit l
Soligenix: A Biotech Bargain Ready To File For Approval In Cutaneous T-Cell Lymphoma
09:40am, Wednesday, 05'th Oct 2022
Soligenix is an underfollowed biotech company trading at a $20 million market cap. The company is about to file an NDA for HyBryte, which I expect to become a first-in-class treatment in cutaneous T-c
Soligenix Shares Gain On HyBrytes Data From Blood Cancer Study
03:19pm, Wednesday, 20'th Jul 2022
Soligenix Inc (NASDAQ: SNGX) announced the results of its Phase 3 FLASH study evaluating HyBryte (synthetic hypericin) for cutaneous T-cell lymphoma (CTCL) had been published in the Journal of the
Soligenix's COVID-19 Vaccine Candidate As Booster Neutralizes Delta, Omicron Variants
09:44am, Thursday, 17'th Mar 2022
Soligenix Inc (NASDAQ: SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non-human primates (NHPs). The data demonstrated ra
Soligenix to Present at the Q1 Virtual Investor Summit
07:30am, Wednesday, 02'nd Mar 2022
PRINCETON, N.J., March 2, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
Soligenix, Inc. to Present at the Q1 Virtual Investor Summit
03:04pm, Tuesday, 01'st Mar 2022
Princeton, New Jersey--(Newsfile Corp. - March 1, 2022) - Soligenix, Inc. (NASDAQ: SNGX) today announced that Jonathan Guarino, Senior Vice President & Chief Financial Officer will be attending the Q1
Soligenix to Present at the 2022 BIO CEO & Investor Conference
07:30am, Tuesday, 08'th Feb 2022
PRINCETON, N.J., Feb. 8, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
Soligenix to Present at Upcoming Investor Conferences
12:30pm, Thursday, 06'th Jan 2022 Business Insider Markets
PRINCETON, N.J., Jan. 6, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need,
Soligenix to Present at Upcoming Investor Conferences
07:30am, Thursday, 06'th Jan 2022
PRINCETON, N.J., Jan. 6, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
Reviewing Rani Therapeutics (NASDAQ:RANI) and Soligenix (NASDAQ:SNGX)
10:36am, Friday, 24'th Dec 2021 Dakota Financial News
Rani Therapeutics (NASDAQ:RANI) and Soligenix (NASDAQ:SNGX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Analyst Recommendations This is a breakdown of current ratings and recommmendations for Rani Therapeutics and Soligenix, […]
Short Interest in Soligenix, Inc. (NASDAQ:SNGX) Expands By 19.8%
07:42am, Wednesday, 22'nd Dec 2021 ETF Daily News
Soligenix, Inc. (NASDAQ:SNGX) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 1,210,000 shares, an increase of 19.8% from the November 15th total of 1,010,000 shares. Based on an average trading volume of 1,690,000 shares, the days-to-cover ratio is presently 0.7 days. SNGX [] The post Short Interest in Soligenix, Inc. (NASDAQ:SNGX) Expands By 19.8% appeared first on ETF Daily News .
Reviewing Soligenix (NASDAQ:SNGX) & CURE Pharmaceutical (OTCMKTS:CURR)
06:28am, Monday, 20'th Dec 2021 Dakota Financial News
Soligenix (NASDAQ:SNGX) and CURE Pharmaceutical (OTCMKTS:CURR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability. Profitability This table compares Soligenix and CURE Pharmaceuticals net margins, return on equity and return on []
Have a gripe on this: ReWalk Robotics Ltd. (NASDAQ:RWLK), Soligenix, Inc. (NASDAQ:SNGX)
12:30am, Thursday, 16'th Dec 2021 Stock Equity
ReWalk Robotics Ltd. (NASDAQ:RWLK) with the stream of 2.40% also noticed, India Soligenix, Inc. (NASDAQ:SNGX) encountered a rapid change of 4.14% in the last hour of Wednesdays trading session. ReWalk The post Have a gripe on this: ReWalk Robotics Ltd. (NASDAQ:RWLK), Soligenix, Inc. (NASDAQ:SNGX) appeared first on Stocks Equity .